Last reviewed · How we verify

NCT04122859: ZIPPED

Evaluation of Zip Device to Conventional Sutures for Laceration Repair in Pediatrics in an Emergency Department

Status unknown NA Last updated 10 October 2019
What this trial tests

NA trial testing Zip Skin Closure Device in Laceration of Skin in 30 participants. Status unknown.

Timeline
1 November 2018
Primary endpoint
1 July 2020
31 July 2020

Quick facts

Lead sponsorZipLine Medical Inc.
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 November 2018
Primary completion1 July 2020
Estimated completion31 July 2020
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

ZipLine Medical Inc.

Who can join

Adults 4 to 14, any sex, with Laceration of Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized, controlled post-market clinical investigation that will enroll pediatric subjects requiring laceration repair. The investigation population will consist of 30 subjects fulfilling the eligibility criteria for the clinical investigation. The subjects will be randomly assigned at a 1:1 ratio to either the Zip 4 Surgical Skin Closure Device group or the Standard of Care sutures group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laceration of Skin

Currently open trials in the same condition.

Other ZipLine Medical Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04122859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing